Laurens van Pinxteren

Laurens’ biotech career spans over two decades of senior positions overseeing CMC development including regulatory quality. Previously, he served as Chief Operation Officer/VP CMC & RA at InteRNA Technologies, Director Manufacturing & Supply at ProFibrix/The Medicines Company, Program Manager at OctoPlus, Business Unit Manager/Consultant at Xendo, and post-doctoral follow at the Statens Serum Institute. Laurens holds a PhD from the University of Edinburgh and an MBA from the Rotterdam School of Management.